Answer
Based on the information you provided, we only know the Q2 2025 revenues:
| Product | Q2 2025 Revenue |
|---|---|
| YORVIPATH® | €103.0 million |
| SKYTROFA® | €50.7 million |
To calculate a year‑over‑year (YoY) growth rate, we would need the corresponding Q2 2024 revenues for each product (or at least the prior‑year figures for the same period). The Yo‑Y growth rate is calculated as:
[
\text{YoY growth (%) } = \frac{ \text{Revenue}{\text{2025}} - \text{Revenue}{\text{2024}} }{ \text{Revenue}_{\text{2024}} } \times 100
]
Because the Q2 2024 revenue figures for YORVIPATH® and SKYTROFA® are not included in the news excerpt you provided, we cannot compute the YoY percentages from the data available.
What would be needed to answer the question
- Q2 2024 revenue for YORVIPATH® (in euros).
- Q2 2024 revenue for SKYTROFA® (in euros).
With those numbers, we could plug them into the formula above to obtain the growth rates for each product.
Next steps
If you have the Q2 2024 revenue numbers (e.g., from the prior‑year earnings release, an annual report, or another news source), share them and we’ll immediately compute the YoY growth percentages for both products.
If that data is not publicly available, you may need to retrieve it from Ascendis Pharma’s prior‐quarter financial disclosures (e.g., the Q2 2024 earnings release, the company’s investor‑relations site, or a financial database). Once you have the numbers, the calculation is straightforward using the formula above.
If you can locate the prior‑year figures, feel free to post them here, and I will promptly provide the exact Yo‑Y growth rates.